Company Overview and News

Sandstorm Gold: Time To Buy?

2018-05-16 seekingalpha
Sandstorm Gold (SAND) has reported its Q1 2018 earnings, and overall, I felt it was an impressive quarter, with the company reporting record quarterly revenue.

Sandstorm Gold: It Will Pay Off To Be Patient

2018-05-16 seekingalpha
Sandstorm gold posted record revenue of $19.5 million for the three months ended March 31, 2018, compared with $18.8 million for the comparable period in 2017.

CANADA STOCKS - TSX rises 0.08 pct, extends winning streak

2018-05-15 reuters
NEW YORK, May 15 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX rose 12.20 points, or 0.08 percent, to 16,097.81. * The biggest contributor to the TSX gain was Canadian National Railway Co, with 10.1 net index points. Industrials were the top sector contributor with 13 net points. * Leading the index were Element Fleet Management Corp, up 12.1 percent, Aphria Inc, up 7.5 percent, and Boyd Group Income Fund, higher by 4.

Which Royalty and Streaming Companies Could Be Rerated in 2018?

2018-05-14 marketrealist
Royalty and streaming mining companies (RING)(SIL) have business models that are considered quite conservative because they don’t own mines. These companies have somewhat fixed income streams after making upfront payments for production rights to mines. This could be why this group of miners has seen higher valuation multiples than miners in other categories.

Sandstorm Gold's (SAND) CEO Nolan Watson on Q1 2018 Results - Earnings Call Transcript

2018-05-12 seekingalpha
Good morning. My name is Chris, and I will be your conference operator today. At this time, I would like to welcome everyone to the Sandstorm Gold conference call. All lines have been placed on mute to prevent any background noise.

Erdene Significantly Increases Resource Estimate at the Altan Nar Gold-Polymetallic Project

2018-05-10 globenewswire
HALIFAX, Nova Scotia, May 10, 2018 (GLOBE NEWSWIRE) -- Erdene Resource Development Corp. (TSX:ERD) ("Erdene" or "Company"), is pleased to announce an updated mineral resource estimate (“Mineral Resource”) for its 100%-owned Altan Nar gold-polymetallic project (“Altan Nar”) in southwest Mongolia.

Aton Announces $2.1 Million Financing Package With Sandstorm Gold Ltd and Concurrent Private Placement for Proceeds Up to $3.0 Million

2018-05-09 globenewswire
VANCOUVER, British Columbia, May 09, 2018 (GLOBE NEWSWIRE) -- Aton Resources Inc. (TSX-V:AAN) ("Aton" or the "Corporation") is pleased to announce that it has signed a $2.1 million financing package (the "Transaction") with Sandstorm Gold Ltd. ("Sandstorm"), which includes the purchase of a royalty by Sandstorm and significant participation by Sandstorm in a $3 million private placement being undertaken by the Corporation (the "Private Placement").

Erdene Establishes Strong Continuity of High-Grade Zones at Bayan Khundii Gold Project With 18 Metres of 21.6 g/t Gold, 36 Metres of 3.8 g/t Gold, and 102 Metres of 1.4 g/t Gold

2018-05-08 globenewswire
HALIFAX, Nova Scotia, May 08, 2018 (GLOBE NEWSWIRE) -- Erdene Resource Development Corp. (TSX:ERD) ("Erdene" or "Company"), is pleased to report results for the first six drill holes from its Q2-2018 drill program at its 100%-owned Bayan Khundii Gold Project (“Bayan Khundii”) in southwest Mongolia.

The Case For Sandstorm Gold: A High Upside, Low-Risk Leverage Play

2018-05-01 seekingalpha
The first quarter uptick in volatility to global markets presents a bullish case for gold markets.

Eldorado Gold: Key Takeaways From Q1 Results

2018-04-27 seekingalpha
Eldorado Gold posted a gain of $8.718 million, or $0.01 per share, for the first quarter. Revenues were $131.91 million up 17.9% from a year ago and up 30% sequentially.

Looking For Exposure To Silver? Consider Wheaton Precious Metals

2018-04-19 seekingalpha
It looks like the precious metals market is preparing for another leg up. If that is the case, silver should perform better than gold.

THIS Market Has Changed And Forever - ValueWalk

2018-04-16 valuewalk
“The world clings to its old mental picture of the stock market because it’s comforting; because it’s so hard to draw a picture of what has replaced it; and because the few people able to draw it for you have no interest in doing so.”

Erdene Commences Drill Program at Bayan Khundii Gold Project

2018-04-11 globenewswire
HALIFAX, Nova Scotia, April 11, 2018 (GLOBE NEWSWIRE) -- Erdene Resource Development Corp. (TSX:ERD) ("Erdene" or "Company"), is pleased to announce the commencement of the 2018 drill program at its 100%-owned Bayan Khundii Gold Project (“Bayan Khundii”) in southwest Mongolia.

Wheaton Precious Metals: What To Do Now

2018-04-09 seekingalpha
It was a strong quarter for the gold & silver streamer, but a disappointing year overall.

Sandstorm Gold Posts Strong Gold Production For The First-Quarter 2018

2018-04-06 seekingalpha
The Company has sold approximately 14,650 attributable gold equivalent ounces during the first quarter of 2018.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 00B7YC668